Is Biolase a Good Medical Device Stock to Add to Your Portfolio?

Published on January 5, 2022

Dental-industry-focused medical device company BIOLASE (BIOL) recently received an extension from Nasdaq to meet the exchange’s minimum bid price requirement and reported revenue growth in the third quarter. However, is...

Continue reading on website
Other news

Top 5 Healthcare Tech Trends Poised for Growth in 2022

January 5, 2022
Best-bet new-arrival innovations include hybrid AI virtual/in-person care as well as precision medicine, but others may surprise you.

Xage snags $30M Series B to help secure critical infrastructure

January 5, 2022
Xage (pronounced Zage) is a startup working to keep critical infrastructure like oil and gas pipelines, water supplies and electrical grids up and running securely. Today, the company announced a $30 million Series B.Piva led the round with participation from Momenta, Valor Equity Partners and OurCrowd, along with existing investors March Capital, City Light Capital, Saints Capital and Saudi Aramc